Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study

BACKGROUND: Glycemic variability is associated with the development of diabetic complications through the activation of oxidative stress. This study aimed to evaluate the effects of a dipeptidyl peptidase 4 inhibitor, vildagliptin, or a thiazolidinedione, pioglitazone, on glycemic variability and ox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Metab (Seoul)
Main Authors: Kim, Nam Hoon, Kim, Dong-Lim, Kim, Kyeong Jin, Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Kim, Sin Gon
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Endocrine Society 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503869/
https://ncbi.nlm.nih.gov/pubmed/28685513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2017.32.2.241
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados